Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $503.00

Intuitive Surgical (NASDAQ:ISRG) had its target price increased by Robert W. Baird from $487.00 to $503.00 in a research note issued to investors on Friday morning, Benzinga reports. They currently have an outperform rating on the medical equipment provider’s stock.

A number of other brokerages have also weighed in on ISRG. Citigroup boosted their price objective on Intuitive Surgical from $462.00 to $512.00 and gave the stock a buy rating in a research report on Wednesday, July 10th. Barclays boosted their price target on Intuitive Surgical from $430.00 to $490.00 and gave the stock an overweight rating in a report on Thursday. BTIG Research raised their price objective on shares of Intuitive Surgical from $451.00 to $459.00 and gave the company a buy rating in a report on Monday, July 15th. Stifel Nicolaus lifted their target price on shares of Intuitive Surgical from $420.00 to $430.00 and gave the stock a buy rating in a research report on Monday, April 8th. Finally, Morgan Stanley upped their price target on shares of Intuitive Surgical from $375.00 to $460.00 and gave the company an equal weight rating in a research report on Monday, July 15th. Six investment analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the stock. According to MarketBeat.com, Intuitive Surgical presently has an average rating of Moderate Buy and a consensus price target of $438.74.

Intuitive Surgical Trading Up 9.3 %

ISRG stock opened at $455.01 on Friday. The stock has a market capitalization of $161.39 billion, a P/E ratio of 82.13, a price-to-earnings-growth ratio of 5.87 and a beta of 1.39. The firm has a 50-day moving average price of $422.05 and a 200-day moving average price of $394.72. Intuitive Surgical has a 12 month low of $254.85 and a 12 month high of $456.81.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 EPS for the quarter, beating the consensus estimate of $1.54 by $0.24. The business had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.40%. The firm’s revenue was up 14.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.18 EPS. As a group, equities analysts predict that Intuitive Surgical will post 4.8 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, Director Alan J. Levy sold 2,000 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, April 23rd. The stock was sold at an average price of $370.70, for a total value of $741,400.00. Following the completion of the sale, the director now directly owns 25,319 shares in the company, valued at $9,385,753.30. The sale was disclosed in a filing with the SEC, which is available at the SEC website. In other news, EVP Myriam Curet sold 5,318 shares of the stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $370.66, for a total transaction of $1,971,169.88. Following the transaction, the executive vice president now owns 298 shares of the company’s stock, valued at approximately $110,456.68. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Alan J. Levy sold 2,000 shares of the firm’s stock in a transaction dated Tuesday, April 23rd. The shares were sold at an average price of $370.70, for a total value of $741,400.00. Following the completion of the sale, the director now owns 25,319 shares of the company’s stock, valued at $9,385,753.30. The disclosure for this sale can be found here. Insiders have sold a total of 17,956 shares of company stock worth $6,927,011 in the last 90 days. Corporate insiders own 0.90% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

Hedge funds have recently added to or reduced their stakes in the company. Baystate Wealth Management LLC lifted its holdings in shares of Intuitive Surgical by 150.0% in the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 45 shares in the last quarter. Creekmur Asset Management LLC increased its stake in Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 42 shares in the last quarter. MCF Advisors LLC raised its holdings in Intuitive Surgical by 108.1% during the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 40 shares during the last quarter. Able Wealth Management LLC bought a new position in shares of Intuitive Surgical in the fourth quarter valued at $28,000. Finally, Delos Wealth Advisors LLC grew its holdings in shares of Intuitive Surgical by 380.0% during the first quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 57 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.